Probiotic microbes: Are their anti-melanogenicity and longevity promoting activities closely linked through the major

Hiroshi Maruta1, Mok-Ryeon Ahn2,3

  • 1PAK Research Center, Melbourne, Australia.

Insights

Probiotic bacteria, like Lactobacillus rhamnosus, show potential for promoting longevity and reducing melanogenesis by blocking the PAK1 pathway. This suggests a link between anti-melanogenic activity and extended lifespan in C. elegans.

Area of Science:

  • Cell Biology
  • Microbiology
  • Gerontology

Background:

  • The protein kinase PAK1 is implicated in shortening lifespan and promoting melanogenesis.
  • PAK1-deficient mutants in C. elegans exhibit extended longevity and reduced melanin production.

Purpose of the Study:

  • To screen for probiotic bacteria and their products that inhibit PAK1 activity.
  • To investigate the potential of anti-melanogenic properties as an indicator for longevity-promoting effects.

Main Methods:

  • Utilized C. elegans as a model organism to assess lifespan and melanogenesis.
  • Examined the effects of Lactobacillus rhamnosus and fermented traditional medicine (ChiBai) on C. elegans.
  • Investigated the role of butyric acid produced by Lactobacillus in blocking the HDAC-PAK1 pathway.

Main Results:

  • Lactobacillus rhamnosus extended C. elegans lifespan by 40%.
  • Fermented ChiBai and Lactobacillus rhamnosus inhibited alpha-melanocyte stimulating hormone (α-MSH)-induced melanogenesis.
  • Butyric acid produced by Lactobacillus blocks the oncogenic HDAC-PAK1 signaling pathway.

Conclusions:

  • Anti-melanogenic activity of probiotics may serve as a reliable indicator for longevity promotion.
  • Lactobacillus-fermented products like Calpis, which inhibit melanogenesis via PAK1, may prolong healthy lifespan.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K